Identifying targets to improve treatment in type 2 diabetes; the Groningen Initiative to aNalyse Type 2 diabetes Treatment (GIANTT) observational study

Pharmacoepidemiology and Drug Safety

Volumn 19, Issue 10, 2010, Pages 1078-1086

  Voorham, Jaco ^a   Haaijer Ruskamp, Floor M ^a   van der Meer, Klaas ^a   de Zeeuw, Dick ^a   Wolffenbuttel, Bruce H R ^a   Hoogenberg, Klaas ^b   Denig, Petra ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MARTINI HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATORVASTATIN; FLUINDOSTATIN; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEALTH CARE QUALITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL, LDL; COHORT STUDIES; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FAMILY PRACTICE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICAL RECORDS; METABOLIC SYNDROME X; MIDDLE AGED; PRIMARY HEALTH CARE; RISK FACTORS;

EID: 79251480736     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2023     Document Type: Article

References (28)

1. Rutten Gehm. Zorg voor patiënten met diabetes mellitus type 2 in de 1e lijn. Ned Tijdschr Geneesk 2008; 152: 2389-2394.
2. Goudswaard AN, Stolk RP, Zuithoff P, Rutten GEHM. Patient characteristics do not predict poor glycaemic control in type 2 diabetes patients treated in primary care. Eur J Epidemiol 2004; 19: 541-545.
3. Meulepas MA, Braspenning JC, de Grauw WJ, et al. Logistic support service improves processes and outcomes of diabetes care in general practice. Fam Pract 2007; 24: 20-25.
4. Redekop WK, Koopmanschap MA, Rutten Gehm, Wolffenbuttel BHR, Stolk RP, Niessen LW. Resource consumption and costs in Dutch patients with type 2 diabetes mellitus. Results from 29 general practices. Diabet Med 2002; 19: 246-253.
5. Steuten LM, Vrijhoef HJ, Landewe-Cleuren S, Schaper N, Van Merode GG, Spreeuwenberg C. A disease management programme for patients with diabetes mellitus is associated with improved quality of care within existing budgets. Diabet Med 2007; 24: 1112-1120.
6. Cleveringa FG, Gorter KJ, van den Donk M, Pijman PL, Rutten Gehm. Task delegation and computerized decision support reduce coronary heart disease risk factors in type 2 diabetes patients in primary care. Diabetes Technol Ther 2007; 9: 473-481.
7. Cleveringa FG, Gorter KJ, van den Donk M, Rutten Gehm. Combined task delegation, computerized decision support, and feedback improve cardiovascular risk for type 2 diabetic patients: a cluster randomized trial in primary care. Diabetes Care 2008; 31: 2273-2275.
8. Gorter K, van Bruggen R, Stolk R, Zuithoff P, Verhoeven R, Rutten GEHM. Overall quality of diabetes care in a defined geographic region: different sides of the same story. Br J Gen Pract 2008; 58: 339-345.
9. Rodondi N, Peng T, Karter AJ, et al. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med 2006; 144: 475-484.
10. Voorham J, Denig P, Wolffenbuttel BHR, Haaijer-Ruskamp FM. Crosssectional versus sequential quality indicators of risk factor management in patients with type 2 diabetes. Med Care 2008; 46: 133-141.
11. Selby JV, Uratsu CS, Fireman B, et al. Treatment intensification and risk factor control: toward more clinically relevant quality measures. Med Care 2009; 47: 395-402.
12. Groningen Giantt. Initiative to Analyse Type 2 diabetes Treatment. http://www.giantt.nl accessed on 25 May 2010.
13. Voorham J, Denig P. Computerized extraction of information on the quality of diabetes care from free text in electronic patient records of general practitioners. J Am Med Inform Assoc 2007; 14: 349- 354.
14. Voorham J, Haaijer-Ruskamp FM, Stolk RP, Wolffenbuttel BHR, Denig P. Influence of elevated cardiometabolic risk factor levels on treatment changes in type 2 diabetes. Diabetes Care 2008; 31: 501-503.
15. Department of Health. Quality and Outcomes Framework: Guidance. London, Department of Health: 2004.
16. van Althuis T. Specification for diabetes indicators from the Dutch College of General Practitioners. 2008 [Specificaties Uitspoelformaat Diabetesindicatoren], http://nhg.artsennet.nl/expertgroepen/steunpuntdiabetes/ praktijkvoering/kwaliteitsmeting-1.htm accessed on 25 May 2010.
17. Rutten Gehm, De Grauw WJC, Nijpels G, et al. 'Diabetes mellitus type 2' guideline (second revision) from the Dutch College of General Practitioners. Huisarts Wet 2006; 49: 137-152.
18. Hayward RA. All-or-nothing treatment targets make bad performance measures. Am J Manag Care 2007; 13: 126-128.
19. Greving JP, Denig P, de Zeeuw D, Bilo H, Haaijer-Ruskamp FM. Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998-2004: a longitudinal observational study. Cardiovasc Diabetol 2007; 6: 25.
20. Kristensen JK, Lauritzen T. Quality indicators of type 2-diabetes monitoring during 2000- 2005. Ugeskr Laeger 2009; 171: 130-14.
21. Khunti K, Gadsby R, Millett C, Majeed A, Davies M. Quality of diabetes care in the UK: comparison of published quality-of-care reports with results of the Quality and Outcomes Framework for Diabetes. Diabet Med 2007; 24: 1436-1441.
22. Proeftuin Farmacie Groningen. http://proeftuinfarmaciegroningen.tmade. nl accessed on 25 May 2010.
23. Pijman PLW, Timmer SJ, Neter RS, Krasser J. Het diabetes zorgprotocol: Hoe staan de bekende diabetespatiënten ervoor? De resultaten van baseline-data vergaard bij het starten van geprotocolleerde diabeteszorg in de huisartspraktijk. Ned Tijdschr Diabetologie 2004; 2: 75-80.
24. Grant RW, Buse JB, Meigs JB. Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change. Diabet Care 2005; 28: 337-442.
25. Grant RW, Cagliero E, Dubey AK, et al. Clinical inertia in the management of type 2 diabetes metabolic risk factors. Diabet Med 2004; 21: 150-155.
26. Guthrie B, Inkster M, Fahey T. Tackling therapeutic inertia: role of treatment data in quality indicators. BMJ 2007; 335: 542-544.
27. Anonymous. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998; 317:703-713.
28. Gorter K, van Bruggen R, Stolk R, Zuithoff P, Verhoeven R, Rutten G. Overall quality of diabetes care in a defined geographic region: different sides of the same story. Br J Gen Pract 2008; 58: 339-345.